Platform Diagnostics Ltd

Home >> About us - shareholders

The principal shareholders of PDL are:
BBI Holdings plc	29.8%	www.britishbiocell.co.uk
Carclo plc	29.8%	www.carclo-plc.com
Rising Stars Growth Fund	17.8%	www.rsgf.co.uk
North West Equity Ventures	13.7%	www.nwef.co.uk
Other	8.9%